Trial Profile
A One-Year, Multicenter, Partially Blinded, Double-Dummy, Randomized Study to Evaluate the Efficacy and Safety of FTY720 Combined With Reduced-Dose or Full-Dose Cyclosporine, USP [Modified] (Novartis Brand) and Corticosteroids Versus Mycophenolate Mofetil Combined With Full-Dose Cyclosporine, USP [Modified] (Novartis Brand) and Corticosteroids, in De Novo Adult Renal Transplant Recipients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary) ; Ciclosporin; Corticosteroids; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Registrational; Therapeutic Use
- Sponsors Novartis
- 01 Nov 2011 Actual end date of the extension trial (NCT00239811) is May 2006.
- 01 Nov 2011 Actual end date of the extension trial (NCT00239811) is May 2006.
- 01 Nov 2011 Actual initiation date of the extension trial (NCT00239811) is Apr 2004.